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Obstructive sleep apnea syndrome (OSAS) is a sleep-disordered breathing condition 
that causes disrupted sleep.  Although OSAS is most often associated with daytime 
hypersomnolence, a number of OSAS patients complain of insomnia, i.e., disorders of 
initiating or maintaining sleep.  If the insomnia in patients with OSAS is secondary to the 
medical condition, then it would be expected to abate with the successful treatment of OSAS.  
If, however, the insomnia is primarily of a psychological nature, thus considered primary or 
psychophysiological insomnia, little to no change in insomnia symptoms would be expected 
after the treatment of OSAS.     
The present study examined the relations between OSAS and insomnia and attempted 
to determine if insomnia is secondary to OSAS by studying changes in insomnia over the 
course of treatment for OSAS with continuous positive airway pressure (CPAP).  Forty-one 
individuals participated in the baseline assessment and a smaller sample of participants (n = 
15) were followed over the course of OSAS treatment.  All participants underwent a nocturnal 
diagnostic polysomnography (PSG) and self-monitored insomnia, daily functioning, sleep 
hygiene practices, and somatic and cognitive pre-sleep arousal for a one-week period prior to, 
and after, CPAP treatment.  Baseline and post-treatment analyses provided evidence 
suggesting that OSAS and insomnia are independent sleep disorders.  There was no 
association between sleep apnea severity and any self-reported measure of insomnia.  
Furthermore, there were no significant changes in insomnia after successful treatment of 
OSAS with CPAP.  There were however, significant reductions in both somatic and cognitive 
arousal, constructs known to be closely associated with insomnia, after CPAP treatment. It is 
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possible that somatic and cognitive arousal decreased as a function of decreased worry and 
anxiety about the sleep disruption typically caused by OSAS.   
Another potential explanation of why insomnia did not improve after CPAP treatment 
involves the significant correlation (r = .59) between CPAP interference and sleep-onset 
insomnia.  These results suggest that a longer adjustment time to the CPAP stimulus might be 
necessary before definitive conclusions are reached regarding the proposed lack of association 
between OSAS and insomnia.  Implications for the assessment and treatment of comorbid 




 Obstructive sleep apnea syndrome (OSAS) is a serious medical condition 
characterized by repetitive partial or complete obstruction of the upper airway during sleep 
(Bassiri & Guilleminault, 2000).  OSAS is the most common condition evaluated at sleep 
disorder centers and has higher rates of morbidity and mortality than any other sleep disorder.  
OSAS is associated with hypertension, increased risk for congestive heart failure, coronary 
artery disease, and myocardial infacrtion (Chervin & Guilleminault, 1996).  OSAS also 
presents serious immediate health consequences, such as excessive daytime sleepiness (EDS), 
which itself can impair cognitive functioning and alertness (Bennett, Barbour, Langford, 
Stradling, & Davies, 1999; Lichstein, Riedel, Lester, & Aguillard, 1999).  An often-cited 
illustration of the potential short-term impact of the EDS associated with sleep apnea, 
involves the 7 times higher rate of automobile accidents involving persons with OSAS 
(Findley, Unverzagt, & Suratt, 1988).  A recent replication study of sleepiness-related 
accidents in sleep apnea patients concluded that those with moderate to severe sleep apnea 
syndrome had a 15-fold risk increase of motor vehicle accidents compared to normal controls 
(Horstmann, Hess, Bassetti, Grugger, & Mathis, 2000).  In addition to the potentially serious 
health consequences of OSAS, undiagnosed OSAS bears a sizable economic cost for the 
United States of America.  Cost data from the year prior to the diagnosis of sleep-disordered 
breathing revealed that patients with undiagnosed sleep apnea required $2720 in medical costs 
compared to $1384 in age and gender matched controls (Kapur et al., 1999).  
Description and Classification of Obstructive Sleep Apnea Syndrome 
An obstructive apnea is characterized by an absence of air exchange at the nose and 
mouth, for 10 seconds or more, with continued thoracic respiratory effort against a closed or 
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obstructed airway.  In addition to complete cessation (decrease by 70%-100%) of airflow 
(apneas), individuals with OSAS commonly experience hypopneas, a reduction (decrease of 
30%-70%) without cessation in airflow or effort.  The exact definition of a hypopnea has been 
more difficult to determine.  Until recently, the standard criteria involved a 10 second or 
greater reduction of airflow of at least 50% (Parkes, 1985).  However, a recent report re-
defined hypopneas in an adult patient as abnormal respiratory events lasting at least 10 
seconds with at least 30% reduction in thorocoabdominal movement or airflow as compared 
to baseline, and with at least a 4% oxygen desaturation (Meoli et al., 2001).  Apneas and 
hypopneas typically last between 20 and 30 seconds and are often accompanied by a decrease 
in arterial oxyhemoglobin saturation (SaO2) (Shepard, 1989).  The extent to which SaO2 
decreases is dependent upon the duration of the respiratory event and the stage of sleep in 
which the event occurs.  Arterial oxyhemoglobin desaturation is almost always greater in 
REM sleep, as opposed to NREM sleep, typically resulting from a lengthening of the apneic 
event (Weiss, Launois, & Anand, 2000). There is also a desensitization of medullary 
respiratory center receptors in REM sleep over and above that, which accompanies NREM 
sleep.   
 These sleep-related respiratory events are often accompanied by a central nervous 
system (CNS) arousal response and an autonomic nervous system (ANS) arousal response, 
which at a minimum, produce transient arousals from sleep, and if great enough, result in 
complete awakenings (Strohl, Sullivan, & Saunders, 1984).   
Transient arousals from sleep are characterized by bursts of alpha waves lasting 
between 3 and 14 seconds, which when they occur repeatedly throughout the night, degrade 
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the overall quality of sleep causing it to be light, discontinuous, and less refreshing or 
restorative (American Sleep Disorders Association, 1992; Bonnet, 1987; Bonnet, 1989).   
 The Apnea + Hypopnea Index (A + HI), also referred to as the Respiratory 
Disturbance Index (RDI), is a measure of the number of sleep-related respiratory events per 
hour of sleep.  The severity of OSAS is frequently determined by an examination of both the 
A + HI and the minimum oxygen saturation.  Mild OSAS is considered to have an A + HI of 
10 - 15 and a minimum SaO2 of approximately 89%, compared to severe OSAS where the    
A + HI must be greater than or equal to 30 and the minimum SaO2 is less than or equal to 
80% (Reite, Ruddy, & Nagel, 1997).  Moderate OSAS is presumed then, to require an A +HI 
of 16 - 29 events per hour of sleep, whereas an A + HI of 5 - 9 would be considered to be 
“borderline”, but is still often diagnosed as OSAS.   
The exact prevalence of OSAS is difficult to determine because of the variability in 
research methodology and procedures used for diagnosing the disorder.  Young et al. (1993) 
reported that OSAS was present in 4% of men and 2% of women between the ages of 30 and 
60, when OSAS was defined as an A + HI of at least 5 and included a presenting complaint of 
EDS.  A recent study revealed a 29% (A + HI = 15) to 43% (A + HI = 5) rate of undiagnosed 
sleep apnea in a sample of older adults (mean age = 69.4 years) with insomnia (Lichstein et 
al., 1999).  Interestingly, this study was concerned with ruling out cases of OSAS and 
therefore required each subject to undergo a thorough clinical interview before participating 
in a diagnostic nocturnal polysomnography.  The results of this study not only provide an 
estimate of the prevalence of sleep apnea in an elderly population presenting with a complaint 
of insomnia, but they highlight the lack of sensitivity clinical interviews may have with 
respect to diagnosing OSAS.   
 
 4
OSAS is more common in men than women, and increases with age, with up to 24% 
of elderly individuals having clinically significant sleep apnea syndrome (SAS), which 
includes both obstructive and central sleep apnea (Ancoli-Israel, Kripke, & Mason, 1987; 
White, 2000).  The gender difference with respect to apnea frequency tends to narrow with 
age, with women experiencing an average of 26 events per hour versus 34 events per hour for 
men (Ware, McBrayer, & Scott, 2000).   
 While OSAS involves an obstruction of the upper airway, central sleep apnea 
syndrome (CSAS) is characterized by a loss of respiratory effort (White, 2000).  A central 
apnea is defined, as a period of at least 10 seconds without airflow, during which there is no 
respiratory effort.  Although OSAS and CSAS are often conceptualized as mutually exclusive, 
in reality most patients present with a combination of obstructive and central apneas; in fact, it 
is rare to diagnose a “pure” case of CSAS (White, 2000).   
Clinical Signs and Symptoms of OSAS  
 The signs and symptoms of OSAS can be categorized according to symptoms during 
sleep and daytime symptoms.  Symptoms that may occur during sleep include snoring, 
abnormal motor activity, nocturnal sleep disruption (insomnia), choking, esophageal reflux, 
nocturia and/or heavy sweating.  Patients may not be aware of, or may deny some of the 
symptoms; therefore, corroboration from family or bed partners is often helpful 
(Guilleminault, 1989).   
Daytime symptoms of OSAS may include excessive daytime sleepiness, cognitive 
impairments, impaired memory and/or concentration, hypnagogic hallucinations, changes in 
personality, sexual problems, headaches and/or loss of hearing.  The vast majority of patients 
will not present with all symptoms, but frequently several will be present.  A clinical 
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assessment including an evaluation of obesity and fat distribution, an examination of the 
oronasomaxillofacial region and other potential aggravating factors such as alcohol use, CNS 
depressant drugs and/or partial sleep deprivation will aid in making the diagnosis.  Ultimately 
an objective evaluation via nocturnal polysomnography (PSG) is the best clinical method for 
diagnosing the presence of OSAS.  During the PSG, the type, frequency, and duration of 
apneas and hypopneas are monitored.  Numerous other symptoms can also be monitored; 
however, they must be chosen carefully due to the increased risk of disrupting the patient’s 
sleep in the laboratory.   
Treatment of OSAS  
 Nasal continuous positive airway pressure (CPAP) has become the major non-surgical, 
long-term treatment for OSAS.  CPAP acts as an air-pressure splint, which maintains the 
patency of the upper airway by providing continuous pressure to the interior of the airway 
thus, preventing it from collapsing (Grunstein & Sullivan, 2000).  The efficacy of CPAP has 
been established in a number of studies with mild to severe forms of OSAS (Monasterio et al., 
2001; Montserrat et al., 2001).   
 Although CPAP is the treatment of choice for OSAS, patient compliance with CPAP 
remains an important focus of the treatment.  Numerous definitions of compliance have been 
proposed (Grunstein & Sullivan, 2000).  For the purposes of this study, compliance will be 
defined as the degree to which patients who accept CPAP treatment for OSAS report actually 
using it.  Few studies have examined the number of patients who accept CPAP as a treatment 
recommendation.  Those studies that have been conducted found that 70% - 76% of patients 
offered a CPAP trial night or the opportunity to take a CPAP machine home accepted the 
recommendation (Grunstein & Sullivan, 2000).   
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 Daily compliance with CPAP is most often measured via self-report estimates of daily 
usage (Hui et al., 2001; Monasterio et al., 2001; Montserrat et al., 2001), although CPAP 
machines that contain built-in usage clocks to record daily use are now available and ideal for 
improving the reliability of the data.  Comparisons of subjective (patient self-report) and 
objective (built-in time clock) measures of compliance consistently show that patients 
overestimate their average use of CPAP by approximately 1 hour per night (Rauscher, 
Formanek, Popp, & Zwick, 1993; Kribbs et al., 1993).  Use of CPAP for more than 4 hours 
per night on more than 70% of the nights and/or symptomatic improvement is generally 
considered a treatment success (Grunstein & Sullivan, 2000; Kribbs et al., 1993).   
Insomnia and OSAS 
 Although OSAS more typically produces a disorder of excessive somnolence, a 
number of cases of insomnia associated with a polysomnographic finding of sleep apnea have 
been reported (George, 2000; Guilleminault, Eldridge, & Dement, 1973).  The disordered 
breathing events often result in transient arousals or complete awakenings from sleep, 
potentially producing disorders of initiating and maintaining sleep.  Sleep fragmentation is 
typically not perceived by classic OSAS patients, however OSAS patients with insomnia are 
more aware of sleep fragmentation and complain of recurrent awakenings and sleep 
maintenance difficulties (Reite, Buysse, Reynolds, & Mendelsohn, 1995).  Insomnia tends to 
be more common in patients diagnosed with central sleep apnea, although mild obstructive 
and mixed apneas also can result in a complaint of insomnia rather than hypersomnolence 
(Fredrickson & Krueger, 1989).  The nature of the apnea may also dictate the type of 
insomnia experienced; that is, patients with sleep onset central apneas are more apt to 
complain about sleep onset insomnia whereas, patients with OSAS may readily fall asleep but 
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repeatedly awaken during the night, thus experiencing sleep maintenance insomnia.  
Polysomnographic findings tend to confirm the apneic patient’s subjective complaint.  In 
patients with OSAS, reductions in total sleep time and sleep efficiency have been noted in 
association with prolonged latency to initial sleep onset and increased wakefulness after initial 
sleep onset (Fredrickson & Krueger, 1989).  Furthermore, the percentage of light and 
transitional stage 1 sleep is typically elevated due to the number of arousals and awakenings.   
 Prevalence rates of the co-occurrence of SAS and insomnia vary widely.  A large 
national cooperative study conducted in 1982 revealed that 31% of participants had a sleep 
onset or sleep maintenance insomnia complaint, but only 6.2% of this group also received a 
diagnosis of sleep apnea (Coleman, Roffwarg, & Kennedy, 1982).  Therefore, it was assumed 
that OSAS was associated with insomnia far less often than with excessive daytime 
sleepiness.  Despite the paucity of research in this area, recent studies have indicated that 
OSAS with insomnia may be more common than was once assumed.  In a group of 45 older 
adults recruited for the treatment of late-life insomnia, 40% were diagnosed with co-morbid 
OSAS (A + HI ≥ 10), and an additional 24% were identified as having and A + HI between 5 
and 9 (Stone, Morin, Hart, Remsberg, & Mercer, 1994).  Krakow et al. (2001) studied sleep 
disturbance in posttraumatic stress disorder and found that insomnia and OSAS co-occurred 
in 50% of the participants studied.  Preliminary follow up data indicated that 85% of the 
participants who were treated with CPAP reported moderate to marked improvement in 
insomnia.  
There are a number of plausible hypotheses as to why some patients with OSAS may also 
experience insomnia.  The following list highlights the most likely explanations for the co-
occurrence of the two disorders:    
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1. Insomnia may be a direct function of OSAS.  Lichstein, Wilson, and Johnson (2000) 
describe two types of secondary insomnia, which suggest that a medical condition 
(e.g., OSAS) is directly responsible for sleep difficulties: (1) Absolute Secondary 
Insomnia refers to the conventional definition of secondary insomnia -- insomnia 
based on psychiatric or medical (including pain or discomfort) disturbance, and; (2) 
Partial Secondary Insomnia, which asserts that the primary disorder affects sleep but 
does not account for 100% of the variability in the insomnia. 
2. OSAS patients wake up, realize they aren’t breathing and are afraid to go back to 
sleep. This scenario is more typically found in patients with CSAS. 
3. Nonrestorative sleep (from frequent awakenings due to OSAS) leads patients to 
develop poor sleep hygiene habits (e.g., napping, staying in bed longer), which 
maintains or exacerbates the insomnia. 
4. Impaired daytime functioning due to hypersomnolence or fatigue contributes to 
increased stress and worry at night.  Stress also increases as a function of worrying 
about not breathing or being frustrated about not sleeping.  This worry and frustration 
serves to perpetuate the insomnia by inhibiting sleep.  
5. Finally, patients may develop conditioned psychophysiological insomnia, which is 
where cues, such as the bedroom, bedtime, and attempting to sleep become associated 
with respiratory pause-induced awakenings and thus produce sleep-initiating arousal.  
This arousal may be in the form of either somatic (physiological) arousal and/or 
cognitive (mental) arousal.  
The purposes of this study were to determine if the insomnia experienced by some 
patients with OSAS is of a primary or secondary nature, by examining whether insomnia 
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improved as a function of treatment of OSAS with CPAP. Theory and empirical evidence 
from the sleep disorders literature informed the following hypotheses for this study. 
Hypotheses 
1. It was hypothesized that the diagnostic A + HI and measures of sleep hygiene and pre-
sleep arousal would be significantly correlated with measures of insomnia and daily 
functioning. 
2. It was hypothesized that diagnostic A + HI and pre-sleep arousal, as measured in the 
first half of the baseline week, would predict significant unique variance in insomnia 
(SOL, WASO), as measured in the last half of the baseline week.    
3. For those participants who were followed over the course of treatment, it was 
hypothesized that all variables of interest would significantly change from baseline 
(pre-CPAP) to post-treatment (post-CPAP).      
         (a) There would be a significant decrease from the diagnostic A + HI to the  
               titration A + HI.  These results would suggest that the CPAP treatment  
               was effective in reducing the apneic events associated with OSAS.  
         (b) Patient-reported insomnia would significantly decrease after treatment of  
        OSAS with CPAP, thus suggesting that the insomnia was secondary to the  
        medical condition (i.e., OSAS). 
   (c) Self-reported sleep hygiene habits would significantly improve from pre- 
                    CPAP to post-CPAP as a result of the specific sleep hygiene counseling    
                     routinely provided after the diagnostic PSG.  It is expected that this change  
                     would be smaller in size compared to the other variables, given the small to  
                     moderate impact sleep hygiene education has been found to have on behaviors. 
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   (d) Pre-sleep arousal was hypothesized to significantly decrease after CPAP    
                     treatment as a function, in part, of less stress and worry about the sleep and  
         related daytime symptoms caused by OSAS.  
4. It was hypothesized that greater CPAP compliance would be correlated with greater 
improvement in insomnia, thus reinforcing a relation between OSAS and insomnia. 
5. It was hypothesized that there would be a significant correlation between changes in  
A + HI and changes in insomnia.  Such findings would provide strong evidence for the 
existence of partial secondary insomnia in patients with OSAS.  If a significant 
relationship between change in OSAS and change in insomnia was identified, then it 
was hypothesized that a hierarchical multiple regression would reveal the following 
results: 
(a) A + HI change would account for statistically significant variance in 
explaining subjective changes in insomnia. 
(b) Changes in pre-sleep arousal would account for statistically significant 
variance in changes in insomnia above and beyond that of the OSAS 
treatment effects alone (i.e., change in A + HI).   
(c) Changes in sleep hygiene would not account for additional statistically 
significant variance in changes in insomnia, since sleep hygiene treatment 
provided in isolation, does not typically improve insomnia symptoms.  
6. For those participants still experiencing insomnia after treatment for OSAS with 
CPAP, it was hypothesized that continued insomnia would be associated with poor 
CPAP compliance and direct interference of the CPAP with the ability to initiate or 





 Sixty-nine participants were recruited from referrals to the Ochsner Clinic Foundation 
of Baton Rouge's Sleep Disorders Center (OCFBR-SDC) for an evaluation of sleep apnea 
syndrome.  Only patients who met the criteria for OSAS as determined from their nocturnal 
diagnostic polysomnography (PSG), and indicated symptoms consistent with insomnia were 
included in the study.  That is, patients must have evidenced a minimum A + HI of 5 and 
reported a period of one month, of three or more nights per week with either sleep onset 
difficulty (30 minutes or greater) and/or sleep maintenance difficulty (one or more nocturnal 
awakenings of at least 30 minutes in duration or three or more awakenings of a least 10 
minutes in duration each).  Of the 69 participants recruited for the study, 23 were excluded 
because they did not meet the diagnostic criteria for OSAS, and 5 participants changed their 
minds about participating before the study period was initiated. Therefore, 41 individuals met 
the inclusion criteria and agreed to participate in this study.  A subset of these participants (n 
= 29) were prescribed and accepted CPAP treatment for OSAS and agreed to participate in 
the post-CPAP treatment phase of the research. Of these 29 participants, 15 individuals 
completed the 2-week post-treatment phase of the study and returned the self-monitoring 
packets. The remaining 14 participants were contacted on several occasions and encouraged 
to return their completed study materials, but they were never received.  
Procedure 
Prior to the patients’ scheduled PSG, a medical history was obtained and a physical 
examination was performed by the patient’s OCFBR-SDC physician.  In addition, all patients  
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completed the Sleep Disorders Inventory (SDI; Waters, unpublished), a self-report 
questionnaire that assesses for signs and symptoms of all major sleep disorders and sleep 
hygiene problems. 
Patients who met the eligibility requirements were approached and asked to participate in 
the current study, which was described as an investigation of the relations between sleep 
apnea and insomnia.  Participants completed a demographic questionnaire and a brief measure 
of self-reported insomnia.  Participants also received a packet of self-monitoring forms 
including sleep diaries and measures of sleep hygiene and pre-sleep arousal.  It was 
emphasized that the research was purely descriptive and would not interfere with their course 
of treatment at the OCFBR-SDC.  All participants understood that they might not be eligible 
to continue in the study if they did not receive a diagnosis of OSAS after completing the PSG. 
The experimenter contacted all participants after the PSG scoring became available to inform 
them as to whether or not they were eligible to continue in the study.   
All participants underwent a standard hook-up procedure for a nocturnal 
polysomnography.  Patients slept in a queen-size bed in a hotel-like room, and a Grass 
Heritage Digital Polysomnograph was used for the PSG recordings.  Gold plated cup 
electrodes were used to monitor electroencephalogram (EEG), submental/chin 
electromyogram (EMG), electro-oculogram (EOG), electrocardiogram (ECG), and anterior 
tibialis EMG.  Nasal and oral airflow was measured using a Pro-Tech breath sensor 
(thermistor).  Respiratory effort (abdominal and thoracic expansion) was monitored with Med 
Associates Sleepmate respiratory belts.  Participants’ sleep position was monitored on video 
using an infrared camera and light source system.  If participants evidenced more than 30 
apneic events before 2 am., they underwent a split-night study in which the second half of the 
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night was used to titrate CPAP treatment.  Otherwise, patients underwent an uninterrupted 
full-night diagnostic PSG and were required to come back to the OCFBR-SDC for a full night 
of CPAP titration, if the diagnostic PSG was positive for OSAS.   
The PSG data was scored by a trained polysomnography technologist at the OCFBR-
SDC.  Each recorded epoch (30 seconds) of sleep was hand scored for respiratory events, 
sleep stages, and EEG arousals; sleep stages and arousals were scored according to 
Rechtschaffen and Kales (1968) and American Sleep Disorders Association (1992) criteria, 
respectively.  A computer-generated summary reported the A + HI (diagnostic) and A + HI 
(titration), which were used as indicators of the presence and severity of OSAS in the current 
study. 
 All participants were contacted by telephone the day the scored PSG data became 
available, and those who meet the eligibility requirements for the study were instructed to 
begin self-monitoring for a 1-week period.  Each morning, participants recorded details about 
their previous night’s sleep (sleep diary), sleep hygiene habits, and pre-sleep arousal.  
 Approximately 3-4 weeks later, those participants who took part in the post-treatment 
phase of the study, returned to OCFBR-SDC to meet with the clinic Director (a clinical 
psychologist, board certified in Sleep Medicine) to discuss the results of their PSG, and the 
ensuing treatment recommendations.  During this meeting, participants received clinical 
feedback regarding their sleep hygiene, as reported on the SDI, which included receiving 
information and a list of “rules” to follow to improve sleep.  A sleep hygiene quiz was 
included with the materials and was used as a manipulation check to ensure that the 
participants read the information. The session concluded with the participants receiving a 
post-test packet of self-monitoring forms.  The participants were instructed to self-monitor 
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daily for 2-weeks after their treatment with CPAP commenced. Only data from the second 
week of self-monitoring was used, to allow time for adjustment to the CPAP stimulus.  The 
post-test packet included all of the self-monitoring forms from the baseline packet plus the 
sleep hygiene quiz and a form inquiring about CPAP compliance, discomfort, and 
interference.  Additionally, these participants completed the self-report measure of sleep 
difficulties at the end of the 2-week monitoring period to reassess insomnia.  Table 1 provides 
a list of assessment measures that were utilized during the course of this research.   
Table 1. 
List of assessment measures and schedule of data collection. 
 Pre-PSG Nocturnal 
PSG 
Baseline Post CPAP 
Sleep Disorders Inventory X    
Insomnia Severity Index X   X 
A + HI  X   
A + HI (titration)    X*   
Sleep Diary (SOL, WASO)   X X 
Sleep Hygiene   X X 
Pre-sleep Arousal   X X 
CPAP Compliance & 
Interference 
   X 
 
* Titration may have occurred during the diagnostic PSG (i.e., split night) or taken place on a 
separate night solely devoted to CPAP titration.  
 
Participants were instructed to mail back the study packets in the addressed and 
stamped enveloped provided.  In an effort to increase compliance with self-monitoring, 
participants received regular telephone calls from the experimenter encouraging them to 
complete the self-monitoring and mail the packet back as soon as possible.  Participants who 




Sleep Disorders Inventory 
 The Sleep Disorders Inventory (SDI; Waters, unpublished) is a 60-item self-report 
measure, based on the International Classification of Sleep Disorders (ICSD), designed to 
assess signs of sleep disorders and dysfunctions.  The SDI, like all other sleep inventories, has 
not been psychometrically validated due to the low baserates of a number of the sleep 
disorders and the enormous cost associated with performing multiple PSGs.  However, it is 
accepted practice to screen for sleep disorders using ICSD criteria (Speilman, Yang, & 
Glovinski, 2000), and the SDI assesses all of the major ICSD classifications (i.e., sleep apnea, 
psychophysiological insomnia, narcolepsy, idiopathic hypersomnia, periodic limb movement 
disorder, restless legs syndrome, shift work sleep disorder, nightmares, inadequate sleep 
hygiene, REM sleep behavior disorder, and insufficient sleep syndrome), as well as 
descriptions of daytime hypersomnolence, insomnia, sleep time allocation, and sleep loss.  
Any responses that were indicative of a possible sleep disorder were followed up with a brief 
interview, based on ICSD diagnostic criteria, by the OCBR-SDC Director at the post-PSG 
interview.  
Insomnia Severity Index 
 The Insomnia Severity Index (ISI; Bastien, Vallieres & Morin, 2001) is a brief self-
report instrument used to measure a patient’s perception of his or her insomnia.  The ISI is 
composed of 7 items that evaluate: (a) sleep-onset insomnia, (b) sleep maintenance insomnia, 
(c) early morning awakening insomnia, (d) satisfaction with current sleep pattern, (e) 
interference with daily functioning, (f) noticeability of impairment attributed to the sleep 
problem, and (g) level of distress caused by the sleep problem.  Each of these items is rated 
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over the past 2 weeks on a 5-point Likert scale.  The ISI has demonstrated adequate internal 
consistency (Cronbach’s alpha = .74; average item-total correlation = .54), concurrent validity 
(r = .45 with PSG sleep onset and r = .37 with sleep diary sleep onset), and sensitivity to 
changes in perceived sleep difficulties, i.e., ISI change scores were significantly correlated 
with change scores from the sleep diary and PSG (Bastien et al., 2001).  In the present study, 
the ISI demonstrated adequate internal consistency (Cronbach’s alpha = .74), but poor 
concurrent validity with other measures of insomnia (r (39) = .11 with PSG sleep onset and r 
(39) = .06 with sleep diary sleep onset latency).  Therefore, the results involving the ISI must 
be interpreted with caution and in the context of other more widely accepted measures of 
insomnia used in this study.  
 Sleep Diary    
A sleep diary (Lacks, 1987) is a daily report of sleep and waking activities.  Sleep 
diaries are widely used in clinical and research settings and have been found to be a reliable 
estimate of sleep/wake patterns over 24-hour period (Rogers, Caruso, & Aldrich, 1993).  The 
Sleep Diary (Lacks, 1987) test-retest reliability is reported to be high for sleep onset latency (r 
= .98), number of arousals (r = .88), and time awake after sleep onset (r = .84).  The Sleep 
Diary also significantly correlates with objective data from PSGs for sleep onset latency (r = 
.62 - .99 depending on criteria used for PSG sleep onset scoring) (Lacks, 1987).  Although 
there are many potential sources of bias with self-monitoring (Korotitsch & Nelson-Gray, 
1999; Nelson, Boykin, & Hayes, 1982), insomniacs tend to consistently overestimate 
wakefulness and underestimate total sleep time and number of arousals (Carskadon et al., 
1976).  Therefore, sleep diaries provide a reliable and valid (although relative) index of sleep 
disturbance (Schoicket, Bertelson, & Lacks, 1988).  The Sleep Diary that was used in the 
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present study reported: bedtime, wake time, how much time taken to fall asleep (SOL), how 
much time spent awake after sleep onset (WASO), and 7-point Likert ratings of sleep 
initiation difficulty, restfulness, sleep quality, level of physical tension at bed, level of mental 
activity at bed, and overall functioning on the previous day.  In the current study, the sleep 
diary served as a subjective measure of sleep difficulties (i.e., sleep onset and sleep 
maintenance insomnia).   
Pre-Sleep Arousal Scale 
 The Pre-Sleep Arousal Scale (PSAS; Nicassio, Mendelowitz, Fussell, & Petras, 1985) 
is a 16-item self-report questionnaire that assesses both somatic and cognitive manifestations 
of arousal prior to sleep.  The PSAS has demonstrated good internal consistency (Cronbach 
alphas = .76 - .88), test-retest reliability (r’s = .72-.76), and concurrent validity (Nicassio et 
al., 1985).  The PSAS also reliably distinguishes between good sleepers and those with 
insomnia, particularly on the basis of the cognitive subscale score; those with insomnia report 
higher cognitive arousal than somatic arousal and more cognitive arousal than good sleepers.  
Both subscales of the PSAS were used in this study to measure arousal prior to sleep and both 
scales demonstrated good internal consistency (Cronbach’s alphas; somatic subscale = .88 and 
cognitive subscale = .88).   
Sleep Hygiene Diary 
 The Sleep Hygiene Diary (Lacks, 1987) is a 20-item checklist inquiring about 
behaviors/situations, which may have interfered with the previous night’s sleep.  The sleep 
hygiene diary was adapted from the Sleep Hygiene Awareness and Practice Scale, which 
examines knowledge about environmental factors that can interfere with sleep and gathers 
information about inadequate sleep hygiene over the past week (Lacks, 1987).  The Sleep 
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Hygiene Diary used in the current study required participants to rate sleep hygiene practices 
on a daily basis.   
Questions were responded to in a Yes/No format, and the inadequate sleep hygiene behaviors 
that were endorsed were assigned a score of 1.  All items were summed to provide a total 
score; higher scores indicated poorer sleep hygiene.   
CPAP Compliance, Discomfort, and Interference 
 For those participants who participated in the post-treatment phase of the study, a 
subjective measure of CPAP compliance was obtained by asking participants to rate, each 
morning, how many hours they wore the CPAP the previous night.  Self-reported CPAP use is 
the most common method of collecting information about CPAP compliance (Hui et al., 2001; 
Monasterio et al., 2001; Montserrat et al., 2001).  Two additional questions were asked 
regarding discomfort/stress and sleep interference from the CPAP.  Participants responded on 
a 7-point Likert scale indicating the extent of any discomfort/stress or interference in sleep 
that was a function of the CPAP (i.e., uncomfortable, noisy, difficulty breathing, dry nasal 
passages).  These questions were created to ensure that the insomnia and pre-sleep arousal 
reported during the post-treatment phase of the research were not a consequence of the CPAP 





Data Screening and Outlier Analysis 
 All measures were initially assessed for multivariate outliers, univariate outliers, and 
distribution skew.  First, the data were assessed for multivariate outliers by entering all 
measures into a multiple regression and computing Mahalanobis distance. A chi-square cut-
off of p < .001 was used as the criterion for multivariate outliers (Tabachnick & Fidell, 1996).  
No multivariate outliers were identified; therefore all cases were retained in the subsequent 
analyses. Univariate outliers were identified by taking 1.5 times the inter-quartile range, and 
declaring as outliers all data points either that distance above the upper quartile or that 
distance below the lower quartile (Hoaglin, Mosteller, & Tukey, 1983).  Ten data points in 
total were identified as univariate outliers. Univariate outliers were Windsorized, which 
involved replacing the outlying data with non-outlying values while retaining the sequential 
order among the outliers (Hoaglin et al., 1983).  Finally, univariate summary statistics were 
computed to identify non-normally distributed measures.  Measures that were non-normally 
distributed (i.e., skew > | 0.7 | ) were transformed according to the direction of the skew. The 
diagnostic A + HI, SOL, WASO, sleep hygiene, somatic arousal, and cognitive arousal 
average scores were positively skewed and transformed accordingly (i.e., square root or 
logarithmic transformations).  Although there were broad ranges of responses across all 
variables, the majority of the participants fell at the lower (i.e., less severe) end of the 
distribution, thus creating the positive skew.  These results suggest that this particular group 
of sleep disordered patients experienced symptoms that were mild to moderate in severity, 




 Participants in this study ranged in age from 30-78 years old with a mean age of 54.0 
years (SD = 10.74).  Of the 41 participants, 56% (n = 23) were male and 44% (n = 18) were 
female.  Racial composition of the sample consisted of 74% (n = 28) Caucasian, 23% (n = 9) 
African American, and 3% (n = 1) other.  Multivariate analyses of variance (MANOVA) were 
computed to test for gender and race differences across the variables used in this study.  
Neither the gender MANOVA, F (7, 32) = 1.46, p > .05 nor the race MANOVA, F (7, 30) = 
3.55, p > .05, were significant, indicating that there were no differential effects of gender or 
race on the dependent variables in this study. The majority of participants, 78%, were 
married, with 12% divorced, and 10% single.   
Analyses of Baseline Data 
 Baseline data was collected on 41 participants, which included measures of OSAS, 
insomnia, and sleep-related behaviors over a 1-week period prior to receiving CPAP treatment 
for OSAS.  Table 2 presents the means and standard deviations of the study variables. In an 
effort to determine if OSAS was associated with insomnia, daily self-monitoring scores were 
averaged over the entire study week and entered into a correlational analysis.    
Table 2.  















Mean 29.84 2.72 2.08 11.57 16.63 32.11 44.34 
Standard 
Deviation 
20.15 .76 1.29 3.68 5.41 20.81 30.15 
 
Note.  A + HI = apnea plus hypopnea index; Daily Fx = daily functioning; SOL = sleep onset 




The first hypothesis of this study proposed that diagnostic A + HI, sleep hygiene and 
pre-sleep arousal would be significantly correlated with measures of insomnia and daily 
functioning.  To test this hypothesis, correlations were computed among diagnostic A + HI, 
sleep hygiene, pre-sleep arousal, daily functioning, and self-reported measures of insomnia.  
The results of the correlational analyses are presented in Table 3.  
Table 3. 
Correlations between sleep apnea, insomnia, and sleep-related behaviors 
 A+HI 
dx 
ISI SOL WASO Fx SH SA CA 
A+HI         
ISI .01        
SOL   -.01 .06       
WASO   -.09 .25    .44**      
Fx    -.02   .31* .14 .10     
SH    .13 .10 .07 .07    .21    
SA .20 .01    .45**    .27    .45** .25   
CA   -.11 .23 .38* .29   .50**     .26   .74**  
 
Note.  * = p < .05; ** = p < .01; A + HI dx = diagnostic apnea plus hypopnea index; ISI = 
insomnia severity index; SOL = sleep onset latency; WASO = wake time after sleep onset;  
Fx = daily functioning; SH = sleep hygiene; SA = somatic arousal; CA = cognitive arousal. 
 
 The objective measure of sleep apnea severity (diagnostic A + HI) was not correlated 
with any subjective measure of insomnia or behaviors associated with insomnia.  However, 
apnea severity was significantly correlated (r (39) = .37, p < .05) with the objective measure 
of WASO, as measured by the PSG.  That is, the more severe the sleep apnea, the higher 
percentage of time the patient spent awake after sleep onset. This finding would be expected 
given the tendency for apneic events to produce transient arousals, thus producing light and 
discontinuous sleep.  Interestingly, A + HI was not correlated with self-reported WASO or 
perceived daily functioning.  Perhaps some participants are unaware of the severity of their 
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OSAS because they do not fully awaken from the apneas during the night and therefore, their 
perception of WASO and daily functioning is based on other information (e.g., SOL, fatigue, 
anxiety).  Finally, the lack of association between the subjective measures of insomnia (i.e., 
ISI and SOL, ISI and WASO) and the significant correlation between ISI and daily 
functioning (r (39) = .31, p < .05) suggests that the ISI may be measuring both the symptoms 
and sequelae of insomnia.   
Consistent with the research literature, both somatic arousal and cognitive arousal 
were significantly correlated with onset insomnia (i.e., SOL). However, in the present study 
of patients diagnosed with OSAS, somatic arousal was more strongly associated with 
insomnia compared to cognitive arousal; a finding that is contrary to previous research, which 
suggests that cognitive arousal, plays a more important role in the development and 
maintenance of insomnia (Lichstein & Fanning, 1990; Nicassio et al., 1985).  Neither somatic 
nor cognitive arousal were correlated with the ISI, providing further support for the 
hypothesis that the ISI may be a more general measure of the consequences of insomnia (i.e., 
interference with quality of life, daily functioning, noticeability to others) rather than a 
measure of insomnia symptoms.   
 Both somatic arousal and cognitive arousal were also significantly correlated with the 
participant’s reported level of daily functioning.  Partial correlations were computed in an 
effort to determine if any of the relations between somatic arousal, cognitive arousal, 
insomnia, and functioning could be accounted for by apnea severity.  None of the partial 
correlations were significant (p > .05), that is, the partial correlations did not change in 
magnitude compared to the original bivariate correlations, when controlling for A + HI.  
Therefore, it appears that apnea severity does not mediate any of the relationships between 
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pre-sleep arousal, insomnia, and perceived daily functioning.  These results provide further 
evidence suggesting a lack of association between OSAS and insomnia. 
 Two stepwise multiple regression analyses were conducted to examine how well 
apnea and insomnia-related behaviors predicted sleep onset and sleep maintenance insomnia.  
These analyses tested the second hypothesis of the study, which proposed that A + HI and 
pre-sleep arousal would predict significant unique variance in insomnia.  The daily self-
monitoring scores were averaged over the first 4 days and the last 3 days of the measured 
baseline week.  The data were analyzed in this manner in order to maximize the number of 
data points while maintaining the temporal precedence among the variables. That is, the 
predictor variables (diagnostic A + HI, sleep hygiene, somatic arousal, and cognitive arousal) 
were averaged over days 1-4, and examined in relation to the criterion variables (sleep onset 
latency (SOL) and wake time after sleep onset (WASO)), which were averaged over days 5-7.  
With respect to SOL, the linear combination of the predictor variables was significantly 
related to onset insomnia, F (1, 38) = 16.67, p < .001.  The sample multiple correlation 
coefficient was .55, indicating that approximately 30% of the variance of sleep onset insomnia 
in the sample could be accounted for by the linear combination of the independent variables.  
Of all of the independent variables included in the analysis, only somatic arousal was 
identified as a unique predictor of onset insomnia, t = 4.08, p < .001.  Similar results were 
found with respect to WASO, in that the regression was significant, F (1, 38) = 8.00, p < .01, 
with only somatic arousal emerging as a significant predictor variable, t = 2.82, p < .01.  
Consistent with the pattern of correlations, the severity of sleep apnea (A + HI) did not 
account for any significant variance in the reported sleep onset or sleep maintenance insomnia 
in patients with OSAS.  It appears that somatic arousal, or physiological symptoms reported 
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prior to sleep, may play an important role in sleep onset and maintenance insomnia in patients 
diagnosed with OSAS.  
Analyses of Post CPAP Treatment Data 
The results of the analyses involving the baseline data set the context for the primary 
analyses of this study, by suggesting that there may be no relation between OSAS and 
insomnia.  A more rigorous test of this hypothesis would involve following patients over the 
course of OSAS treatment and examining any changes in reported insomnia.  In order to test 
these primary hypotheses regarding the potential association between OSAS and insomnia, 
individuals who completed the baseline assessment, were followed over the course of 
treatment for OSAS (n = 15).  If patients received an effective treatment for OSAS (i.e., 
CPAP), experienced improvement in sleep apnea symptoms, but did not report any changes in 
insomnia, further evidence would be provided supporting the independence of these two sleep 
disorders. However, the relatively small number of participants who completed this phase of 
the research limits the statistical power and therefore precludes anything other than tentative 
conclusions.  
 There were a number of participants who completed the baseline assessment but were 
not included in the post-treatment analyses for the following reasons: they were never 
prescribed CPAP treatment for OSAS, they were prescribed, but did not accept CPAP 
treatment, or they did not complete the self-monitoring forms and were considered dropouts 
from the post-treatment phase.  In an effort to ensure that there were no systematic differences 
between those individuals who only completed the baseline assessment and those who were 
involved in both phases of the research, analyses were conducted that compared the two 
groups of participants on demographic variables and the sleep variables of interest in this 
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study.  A multivariate analysis of variance (MANOVA) was conducted, where the 
independent variable was whether or not the participant was included in both sets of analyses, 
and the dependent variables were those measures that were assessed during the baseline 
assessment such as, age, diagnostic A + HI, insomnia severity index, sleep hygiene, somatic 
arousal, and cognitive arousal. The overall MANOVA was not significant (p > .05) indicating 
that there were no significant differences between the groups on the continuous measures used 
in this study.  Chi-square tests of independence were performed on the two nominal variables 
(gender and race) to determine if the proportion of participants in each demographic category 
differentially changed from baseline to post-treatment.  Neither the gender chi-square χ (1) = 
.53, p > .05, nor the race chi-square χ (1) = .13, p > .05 was significant indicating that the 
baseline and post-treatment groups did not differ in gender or racial distribution.  Taken 
together, these analyses suggest that there were no significant differences, based on 
demographics or symptoms measured, between those participants involved in the two phases 
of the research.  
 To examine the post-treatment research hypotheses, the same set of analyses were 
performed with the post-treatment data as were conducted with the baseline data, as well as 
other analyses intended to specifically address the hypotheses regarding change in insomnia 
as a function of OSAS treatment with CPAP.  All of the results based on the analyses of the 
post-treatment data should be interpreted with caution due to the small number of participants 
included in this portion of the research.   
 Self-monitoring data was collected for a 2-week period after the initiation of treatment 
of OSAS with CPAP. Only data from the last week was utilized in the analyses in an attempt 
to allow the participants time to acclimate to the CPAP stimulus. As with the baseline data, all 
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scores were averaged over the entire week and correlations were computed among the sleep 
variables. Table 4 presents the means and standard deviations of the post-treatment sleep 
apnea and sleep variables.  
Table 4. 
















Mean 11.56 2.21 1.55 9.65 14.22 29.38 31.47 
Standard 
Deviation 
7.33 .59 .70 1.52 5.45 26.17 22.75 
 
Note.  A + HI = apnea plus hypopnea index; Daily Fx = daily functioning; SOL = sleep onset 
latency; WASO = wake time after sleep onset 
 
 Table 5 presents the correlations that were computed among the sleep variables 
measured after CPAP treatment was initiated. Similar to the baseline data, there continued to 
be an association between somatic arousal, cognitive arousal and sleep onset latency, while 
there was no relationship between post-treatment A + HI and any of the sleep variables.  
Two stepwise multiple regression analyses were conducted to determine if the post-
treatment results replicate the findings from the baseline data, which identified somatic 
arousal as a unique predictor of onset and maintenance insomnia.  Once again, the daily self-
monitoring scores were averaged over the first 4 days and the last 3 days of the measured 
week.  The predictor variables were, post-treatment A + HI, post-treatment sleep hygiene, 
post-treatment somatic arousal, post-treatment cognitive arousal and the criterion variables 
were post-SOL and post-WASO, respectively.  Neither of the regressions were significant; 
however, a power analysis with 4 independent variables and power set at .80, revealed that a 
minimum of 23 individuals would be needed to detect a large effect size. Given that the 
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magnitude of the correlations between somatic arousal and SOL at baseline and post-
treatment are similar, it is likely that the lack of statistical power greatly impacted these 
regression analyses.  
Table 5. 
Correlations between post treatment apnea, insomnia, and sleep-related behaviors 
 A+HI  
titration 
ISI SOL WASO Fx SH SA CA 
A+HI         
ISI   -.50        
SOL    .25 .09       
WASO   -.14 .37    .62*      
Fx    -.46    .37    -.26 .21     
SH    .29   -.09  .12   -.32   -.21    
SA    .29 .08    .54*     .06  - .09 .47   
CA    .25 .13     .57* .11   -.11     .45   .67**  
 
Note.  * = p < .05; ** = p < .01; A + HI titration = apnea plus hypopnea index with CPAP at 
optimal pressure; ISI = insomnia severity index; SOL = sleep onset latency; WASO = wake 
time after sleep onset; Fx = daily functioning; SH = sleep hygiene;    SA = somatic arousal; 
CA = cognitive arousal. 
 
A series of dependent t-tests were conducted to test the third set of hypotheses 
involving the change in sleep apnea, insomnia, and sleep related variables from baseline to 
post-CPAP treatment.  Table 6 presents the results and effect sizes for all variables of interest 
in this study. The significant decrease in the A + HI suggests that CPAP was an effective 
treatment for OSAS, which was accompanied by a significant improvement (lower score 
indicates less impairment) in daily functioning.  Sleep hygiene did not significantly improve 
from baseline to post-treatment when sleep hygiene education was provided prior to initiating 
CPAP; however, mean sleep hygiene scores did decrease (lower score indicates better sleep 
hygiene) from baseline to post-treatment and produced a moderate effect size, which suggests 
that inadequate power (i.e., small sample size) may have been a factor in the failure of the 
 
 28
statistical test to reach significance.  Finally, without any specific intervention targeting pre-
sleep arousal, both somatic arousal and cognitive arousal decreased significantly after the 
initiation of CPAP; however, there was no concurrent improvement in any of the measures of 
reported insomnia (i.e., ISI, SOL, WASO).  
Table 6. 
Baseline and post-treatment results for sleep apnea and sleep-related variables. 




t p d 
A + HI 30.36 8.25 3.74 .002* .99 
ISI 15.47 14.13 1.76 .106 .44 
SOL 31.09 29.39 .39 .702 .10 
WASO 37.51 31.48 1.10 .286 .28 
Daily Functioning 2.74 2.21 3.36 .005* .87 
Sleep Hygiene 2.24 1.55 2.04 .060 .53 
Somatic Arousal 11.43 9.65 3.37 .005* .87 
Cognitive Arousal 17.29 14.22 2.13 .049* .56 
 
Note.  A + HI = apnea plus hypopnea index; ISI = insomnia severity index;  
SOL = sleep onset latency; WASO = wake time after sleep onset 
 
 Although there was no significant improvement in insomnia over the course of 
treatment of OSAS, it is possible that change in apnea symptoms was associated with change 
in sleep variables.  To examine this hypothesis, residualized change scores were created for 
all sleep apnea and sleep variables, and correlations were computed among these change 
scores.  The change in A + HI was unrelated (p > .05) to the change in all insomnia related 
variables (i.e., ISI, SOL, WASO, daily functioning, sleep hygiene, somatic arousal, cognitive 
arousal), thus reinforcing the findings from the baseline analyses, which suggested that there 
was no relation between OSAS and insomnia.  There were however, significant correlations 
between the change in variables assumed to be related to insomnia.  Change in sleep hygiene 
was significantly correlated with change in cognitive arousal (r (13) = .57, p < .05), and 
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although not significant, change in sleep hygiene was moderately correlated with change in 
somatic arousal (r (13) = .46, p = .08).  Furthermore, change in cognitive arousal was 
significantly correlated with change in the length of time taken to fall asleep (SOL; r (13) = 
.54, p < .05).  There was no significant correlation between change in sleep hygiene and 
change in daily functioning.  These results, although correlational and very tentative given the 
small sample size, can be said to suggest that the sleep hygiene intervention provided in this 
study may have been useful in promoting change in behaviors found to be associated with the 
development and maintenance of insomnia, namely, somatic and cognitive arousal.  
 Although a number of important insomnia-related variables improved over the course 
of treatment for OSAS, the participant’s reported insomnia did not change.  Two of the 
possible explanations for this finding include, noncompliance with CPAP treatment for OSAS 
and interference of the CPAP stimulus itself on sleep.  It was hypothesized that greater CPAP 
compliance would be associated with greater improvement in insomnia, thereby providing 
evidence for the relations between OSAS and insomnia.  Adequate compliance with CPAP 
was reported (4.89 hours per night), but there were no significant correlations between CPAP 
compliance and the measures of insomnia.  There was however, a significant positive 
correlation between CPAP interference and SOL (r (13) = .59, p < .05), indicating that the 
more the participant perceived the CPAP to interfere with the ability to sleep, the longer it 
took to fall asleep (i.e., higher SOL). Although not significant, there was an indication that a 
similar relationship may exist between CPAP interference and WASO (r (13) = .49, p = .06).  
While the overall level of interference was not particularly high (a rating of 2 on a 0-6 scale), 
these results do suggest that the perceived interference from the CPAP itself may play a role 
in the persistence of insomnia in the face of significant decreases in other variables previously 
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demonstrated to maintain insomnia.  That is, any potential improvements in insomnia that 
may have occurred as a result of changes in factors known to influence insomnia (i.e., pre-
sleep arousal, sleep hygiene), may have been masked by the adverse effect CPAP had on the 




 The purpose of this study was to examine the association between obstructive sleep 
apnea syndrome (OSAS) and insomnia and determine if insomnia in OSAS patients is 
secondary to OSAS, or is a primary disorder that requires its own treatment.  The baseline 
analyses of 41 individuals diagnosed with OSAS and insomnia provided preliminary evidence 
to suggest that OSAS and insomnia are independent conditions.  The diagnostic Apnea plus 
Hypopnea Index (A + HI), a measure of OSAS severity, was not correlated with any self-
reported insomnia or sleep related behaviors.  Furthermore, partial correlations confirmed that 
A + HI was not mediating the associations among other sleep-related variables, namely: 
somatic arousal, cognitive arousal, daily functioning, and insomnia.  Finally, multiple 
regression analyses failed to identify A + HI as a unique predictor of either sleep onset latency 
(SOL) or wake time after sleep onset (WASO). 
Both somatic arousal and cognitive arousal were significantly correlated with sleep 
onset insomnia, which is consistent with the literature on psychophysiological insomnia 
(Lacks, 1992; Nicassio et al., 1985). However, in this study, somatic arousal was more 
strongly correlated with insomnia than cognitive arousal, and emerged as the only significant 
predictor of either SOL or WASO.  Previous research has suggested that while both forms of 
pre-sleep arousal are important contributing factors to insomnia, cognitive arousal is more 
closely related to nightly SOL (Lichstein & Fanning, 1990; Nicassio et al., 1985; Wicklow & 
Espie, 2000).  Perhaps somatic arousal plays a more prominent role in individuals diagnosed 
with both insomnia and OSAS.  There are a number of well-documented acute physiologic 
changes that are associated with apneic events: Heart rate, systemic arterial blood pressures, 
and pulmonary arterial blood pressures increase markedly at the termination of apneas 
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(Chervin & Guilleminault, 1996).  It might be that because of these frequent physiologic 
changes during the night, patients with OSAS experience more somatic arousal in general 
compared to those individuals diagnosed with insomnia only.  If the insomnia that is 
comorbid with OSAS is, in fact, conditioned psychophysiological insomnia, the somatic 
arousal experienced as a result of apneic events may become conditioned to the bedroom and 
attempts to sleep, thus producing a heightened state of somatic arousal prior to sleep onset.  
That is, the somatic arousal produced from the OSAS acts as a maintaining factor for the 
insomnia.  This theory would be particularly relevant for those individuals who remember 
having OSA-related arousals at sleep onset and during the night.   
A study examining changes in state and trait anxiety of OSAS patients treated with 
CPAP found that while trait anxiety decreased significantly after one month, state anxiety did 
not decrease until after three months of CPAP treatment (Sanchez, Buela-Casal, Bermudez, & 
Casas-Maldonado, 2001).  The fact that, in this study, state anxiety took three times longer to 
decrease after treatment than trait anxiety, provides some evidence indicating that somatic 
arousal may be a conditioned response and therefore more difficult to extinguish (i.e., 
decrease) after the treatment of OSAS.     
Since not all patients with OSAS also have insomnia, it would be interesting for future 
research to investigate if patients with both conditions are characteristically different than 
those individuals with either OSAS or insomnia alone.  Vincent and Walker (2001) studied 
the construct of anxiety sensitivity, fear of anxiety and the consequences of anxiety, in 
patients with insomnia and found that anxiety sensitivity predicted sleep-related impairment.  
Perhaps there is an association between anxiety sensitivity and awareness of OSAS-related 
arousals, that is, higher anxiety sensitivity predisposes an individual to take more notice of 
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physiological changes in the body and thus perceive more somatic arousal.  In order to fully 
test these hypotheses, it would be necessary to conduct another study, which had OSAS-only 
and insomnia-only control groups.  
 There were a number of post-CPAP treatment findings, which also suggested that 
OSAS and insomnia are independent sleep disorders.  The significant decrease in A + HI 
suggested that CPAP was effective in reducing the number of apneic events throughout the 
night, and the significant improvement in functioning suggested that CPAP improved the 
participants’ functioning during the day.  However, the significant decrease in A + HI had no 
relation to self-reported insomnia, as measured by the ISI, SOL, and WASO, but was 
associated with a decrease in somatic and cognitive arousal.  Taken together and interpreted in 
the context of the results from the baseline analyses, it appears that insomnia in patients with 
OSAS is not caused by the OSAS itself, however, improvement in OSAS is related to other 
variables involved in the development and maintenance of insomnia (i.e., somatic arousal and 
cognitive arousal).  
Despite there being no intervention implemented specifically for pre-sleep arousal in 
this study, both somatic arousal and cognitive arousal decreased significantly from baseline to 
post-CPAP treatment.  Also, although not significant with 15 participants (p = .06), mean 
sleep hygiene scores decreased after the sleep hygiene education, suggesting that the 
intervention itself, or potentially the reactivity of the daily self-monitoring of sleep hygiene 
practices, had some impact on self-reported sleep hygiene practices.  Alternatively, improved 
sleep due to CPAP treatment may have reduced the need for participants to engage in 
maladaptive attempts to obtain more sleep.  Similarly, it is possible that somatic arousal and 
cognitive arousal improved as a function of receiving treatment for OSAS. That is, patients 
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may have less somatic arousal because they are having fewer apneas and associated arousals 
and less cognitive and somatic arousal because they are less worried and anxious about the 
cessation of breathing, disrupted sleep, and impairment of daily functioning.    
Finally, it was found that the change in sleep hygiene (from baseline to post-treatment) 
was significantly correlated with change in cognitive arousal and that the change in cognitive 
arousal was significantly correlated with change in sleep-onset insomnia (i.e., SOL).  Perhaps 
learning a variety of new sleep-promoting behaviors gave participants a sense of control over 
their sleep, which resulted in less cognitive arousal leading to a decrease in the length of time 
to fall asleep.  Future studies utilizing structural equation modeling techniques would be 
necessary to test these causal hypotheses.   
Given the significant decrease from baseline to post-treatment in three variables that 
are known to be associated with insomnia (i.e., somatic arousal, cognitive arousal, and sleep 
hygiene), it was expected that insomnia would have improved as well.  Contrary to the 
hypotheses in this study, insomnia did not change after treatment of OSAS with CPAP.  The 
moderate to strong correlation between CPAP interference and insomnia (r = .59) suggests 
that any improvement in insomnia that may have occurred as a result of change in other 
factors may have been negated by the interference of the CPAP stimulus itself. It would be 
interesting to determine if a point exists where the CPAP stimulus is no longer considered an 
interference and if changes in insomnia would occur at that time.  
 This study represents the first attempt to understand the nature of the relations between 
obstructive sleep apnea syndrome and insomnia.  Insomnia has a long history of being 
considered “secondary” to other medical or psychological problems. Harvey (2001) 
empirically examined the assumption that insomnia is better described as a symptom as 
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opposed to a stand-alone diagnosis.  She reviewed numerous studies involving the presence of 
insomnia and another medical or psychological condition (primarily depression), and 
concluded that although insomnia is a symptom and often comorbid with a range of other 
disorders, the idea that insomnia is “secondary” was unfounded.  Her conclusions were based 
on evidence which indicated that depression is predicted by the presence of prior insomnia, 
effective interventions for the primary disorder do not necessarily alleviate the insomnia (as 
was the case in the present study), and that insomnia has been identified as a risk factor for the 
development of other psychological disorders.  As a result of these findings, she questioned 
the extent to which the primary/secondary distinction is valid.   
 There are limitations of the current study, which must temper the conclusions being 
drawn.  The relatively small number of participants who were followed over the course of 
treatment for OSAS limited statistical power and the scope of analyses available.  It was 
encouraging, however, that even with less than ideal power, a number of significant results 
emerged that corroborated the findings based on the baseline analyses with all participants.  
The nonequivalence between samples sizes at baseline and post-treatment also indicates that a 
number of participants dropped out from the study.  Although analyses revealed no significant 
differences on baseline measures between those who completed the study compared to those 
who dropped out, numerous other variables exist, which were not tested that may have 
identified some systematic difference between the groups of participants (e.g., depression, 
anxiety, personality factors, other medical conditions).   
 The presence of two potential interventions for insomnia (i.e., CPAP treatment and 
sleep hygiene education) seriously limits any firm conclusions that can be drawn about the 
impetus for change in insomnia-related variables. In the present study, insomnia did not 
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significantly change over the course of treatment, which supports previous research that states 
that sleep hygiene interventions presented in isolation typically do not improve insomnia 
(Harvey, 2000), and also suggests that treatment for OSAS has little impact on insomnia.  
Despite the lack of change in insomnia, other factors that are correlated with insomnia, such 
as somatic arousal and cognitive arousal did significantly decrease over the course of 
treatment.  Unfortunately, it is difficult to know whether the decrease in pre-sleep arousal is 
attributable to the OSAS treatment, the sleep hygiene education, or a combination of both 
interventions.  
 Future studies could address these issues by including an insomnia-only control group 
and ensuring that no other interventions for insomnia are presented during the CPAP 
treatment phase.  Furthermore, it is recommended that a longer period be given for the 
participants to adjust to the CPAP stimulus.  Collecting information about insomnia after a 
period of a month of wearing the CPAP should be sufficient time to rule out the possibility 
that the insomnia is being maintained or exacerbated by the CPAP stimulus itself.  
 A replication of the results of the present research from studies that incorporate the 
strategies suggested to address the current limitations, would have a number of implications 
for the treatment and management of patients with comorbid OSAS and insomnia.  Patients 
who present to sleep clinics should be adequately assessed for both OSAS and insomnia.  
Since OSAS is often considered a more “serious” disorder, the majority of time and resource 
allocation is spent on its assessment and diagnosis.  However, a thorough assessment of the 
insomnia will help identify the treatment strategies that will be of most benefit to the patient, 
since it appears unlikely that the insomnia would be helped by CPAP treatment.  With respect 
to OSAS treatment, for those patients who present with comorbid psychophysiological 
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insomnia, it may be particularly important to spend time assisting the patient in acclimating to 
the CPAP stimulus before they begin using it at night.  Previous research has shown that 
education and instruction can help patients become acclimated to the CPAP stimulus in a 
relatively short period of time (Edinger & Radtke, 1993; Rains, 1995).  This may be an 
important part of treatment since the results from the present study suggest that interference 
from the CPAP stimulus is associated with continued sleep-onset insomnia.  Although not 
tested in the current study, it is possible that for those patients with conditioned 
psychophysiological insomnia, the CPAP itself could be another stimulus to which 
hyperarousal and frustration about sleep difficulties may become conditioned.  
Finally, it would be necessarily to provide treatment for both OSAS and insomnia. 
Future research would need to determine if there is an optimal order in which to present these 
treatments.  Insomnia has been found to be among the most common psychological health 
problems (Canals, Domenech, Carbajo, & Blade, 1997) and is comorbid with a number of 
medical and psychological problems, including other sleep disorders.  Poor sleepers 
consistently report impaired health, mood, work efficiency, relationships, and a sense of well-
being (Lacks & Morin, 1992).  Therefore, it is incumbent upon the health professionals within 
the field of sleep medicine to provide all the treatments necessary to allow the patient to 
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